Interações medicamentosas
Dichlorphenamide + Empagliflozin-metformin
Gravidade: Grave
Dichlorphenamide and Empagliflozin-metformin: major interaction.
Última atualização
Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.
O conteúdo clínico desta página está disponível apenas em inglês.
Resumo
Dichlorphenamide, a carbonic anhydrase inhibitor, causes hyperchloremic metabolic acidosis. Metformin carries a risk of lactic acidosis, and SGLT2 inhibitors carry a risk of ketoacidosis, so the combined acid-base burden is a concern.
O que esta interação significa em palavras simples
Dichlorphenamide and Empagliflozin-metformin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Dichlorphenamide belongs to Miscellaneous; Empagliflozin-metformin belongs to Endocrine.
Por que acontece
Additive acidosis through bicarbonate loss from carbonic anhydrase inhibition and the acid-base effects of metformin and empagliflozin.
O que fazer
Monitor serum bicarbonate and electrolytes at baseline and periodically, and reassess therapy if metabolic acidosis develops or persists.
O que perguntar ao farmacêutico
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Para assinantes do Pro+
Desbloqueie a página completa
Crie uma conta e comece um teste do Pro+ para desbloquear a orientação completa de conduta para Dichlorphenamide e Empagliflozin-metformin, as notas adicionais, os detalhes da evidência e o verificador de interações para uma prescrição completa.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Experimente o Pro+ grátis por 7 dias na web. Sem cartão.
Outras interações de Empagliflozin-metformin
Outras interações de Dichlorphenamide
Perguntas frequentes
Can I take Dichlorphenamide with Empagliflozin-metformin?
MediHelp rates the interaction as major. Dichlorphenamide and Empagliflozin-metformin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Dichlorphenamide, a carbonic anhydrase inhibitor, causes hyperchloremic metabolic acidosis. Metformin carries a risk of lactic acidosis, and SGLT2 inhibitors carry a risk of ketoacidosis, so the combined acid-base burden is a concern.
How serious is the interaction between Dichlorphenamide and Empagliflozin-metformin?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum bicarbonate and electrolytes at baseline and periodically, and reassess therapy if metabolic acidosis develops or persists.
What other medicines interact with Empagliflozin-metformin?
MediHelp also lists interactions of Empagliflozin-metformin with, for example, Contrast media, Diatrizoate meglumine / diatrizoate, Diatrizoate. The full list is on the Empagliflozin-metformin page.
Monografias completas, posologia e verificador de interações no app MediHelp
Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.
